According to a PubMed.gov 2004 study, which just happens to be the NIH (U.S. National Library of Medicine National Institutes of Health),
Infection of PCV1 was observed with 293, Hela and Chang liver cells, infection with PCV2 only in Rd cells. In addition, religated viral DNA of PCV1 and PCV2 has been used to transfect adherent human cell lines.
The World Health Organization began recommending in 2009 that all Nations include this vaccination in their immunization program. Based on research during a clinical trial in which GlaxoSmithKline surprisingly enough participated in the funding.